Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,396
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
for
Graft Versus Host Disease in Eye, Ocular Complications,
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT06874283
Recruiting
Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Location: Baltimore MD, New York NY, Durham NC, Boston MA,
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06435000
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Baltimore MD, Lancaster PA, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
for
Stargardt Disease, Cone Rod Dystrophy,
Location: Baltimore MD, Boston MA, Cincinnati OH, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc
Sex: All
Age: 12+
Code: NCT06467344
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Baltimore MD, Lancaster PA, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase3, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Baltimore MD, Philadelphia PA, Kingston PA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: Baltimore MD, New York NY, Toronto, Grand Rapids MI,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase3, Recruiting
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
for
Glaucoma
Location: Baltimore MD, Chapel Hill NC, Buffalo NY, Toronto,
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05924477
Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Baltimore MD, Lancaster PA, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: Bayer
Sex: All
Age: 0+
Code: NCT04142437
Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)